Company News

March 20, 2025

Menten AI at NextGen BioMed and BIO-Europe Spring

Menten AI showcased peptide drug innovations at NextGen Biomed and BIO-Europe Spring, strengthening industry connections and advancing the future of peptide-based drugs.

November 1, 2024

Hans Melo Presents at Bio-Europe 2024 in Stockholm

Menten AI's CEO, Dr. Hans Melo, will be sharing the latest developments at Menten AI in Stockholm on adding drug-like properties including plasma stability and membrane-permeability.

August 14, 2024

Hans Melo to Present at BPS 2024

Menten AI's CEO, Dr. Hans Melo, will be sharing the latest developments at Menten AI in Boulder on adding drug-like properties including plasma stability and membrane-permeability.

March 20, 2024

Menten AI Participates in BioEurope Spring 2024

Dr. Melo, CEO of Menten AI, emphasized at the Spring BioEurope conference the substantial decrease in design timelines enabled by our platform, and reiterated the company's dedication to aiding partners in their drug discovery initiatives.

March 19, 2024

Biotech Special: Computational Drug Discovery with Patrick Finneran

Dr. Finneran's recent appearance on Software Engineering Daily highlights Menten AI's significant commitment to computational drug discovery, as he discussed the intersection of our platform with software engineering and AI.

March 11, 2024

Menten AI at the 2024 Winter RosettaCon

Dr. Patrick Finneran represented Menten AI at Winter RosettaCon 2024 and discussed how Menten AI uses physics based generative AI to design cyclic peptides with drug-like properties.

February 28, 2024

Menten AI Joins the Ginkgo Technology Network

Menten AI joins Ginkgo Technology Network to enhance R&D with advanced AI for cyclic peptide design, helping partners achieve optimal outcomes.

January 19, 2024

Milestone Achievement: Menten AI Contributes to Thought Leadership

Menten AI co-authors chapter on quantum computing in Wiley’s new book "Computational Drug Discovery: Methods and Applications" where quantum computing is discussed in the context of computational drug design.

July 1, 2023

Menten AI at APS 2023

Dr. Stephan Kudlacek represented Menten AI at APS 2023 this year and discussed how Menten AI developed the world’s most advanced generative AI platform for the design and optimization of macrocyclic peptide therapeutics.

May 27, 2021

Menten GCN Library release

Menten AI releases Menten GCN: a python library to create GCN tensors from protein models for machine learning.

May 5, 2021

XENet paper

We’re excited to release XENet a new graph convolution that allows larger protein design problems to fit onto near-term quantum computers.

June 4, 2020

New Nature Methods Paper

Fresh off the press! New Nature review of tools for macromolecular design developed in the last 5 years by the Rosetta community. Including Menten AI's team members Jack Maguire and Vikram K. Mulligan.

April 13, 2020

YC W20

We're super excited to announce that Menten AI is now funded by Y Combinator! We're extremely grateful to everyone at Y Combinator for their guidance, especially in these unprecedented times.❤️🙏

September 2, 2019

Designing Peptides on a Quantum Computer

Our approach, Qpacker, demonstrates that quantum-annealer-based design can be applied to complex real-world design tasks, producing designed molecules comparable to those produced by widely adopted classical design approaches.

July 24, 2019

De Novo Design Of Bioactive Protein Switches

Allosteric regulation of protein function is widespread in biology, but is challenging for de novo protein design as it requires the explicit design of multiple states with comparable free energies.

Press Coverage

June 23, 2024

Macrocyclic peptides: Aiming for the perfect fit

C&EN featuring Menten AI and co-founder Vikram Mulligan on the potential of peptide macrocycles as drugs.

May 28, 2024

Menten AI Announces Completion of Research Collaboration with Bristol Myers Squibb

A collaboration with BMS leverages Menten AI’s generative AI platform to accelerate the design and optimization of peptide macrocycles.

May 30, 2022

The Road to the Hybrid Quantum-HPC Data Center Starts Here

Quantum computing has the potential to bust through some of today’s toughest challenges, advancing everything from drug discovery to weather forecasting. In short, quantum computing will play a huge role in HPC’s future.

January 27, 2022

EEE Quantum Announces the Quantum Computing Healthcare Summit Scheduled for 2 February 2022

Registration is free for this online quantum computing conference featuring innovation-centered talks by the chief executives shaping the future of quantum computing and world-leading business experts

January 25, 2022

MENTEN AI PARTNERS WITH XANADU TO DEVELOP QUANTUM MACHINE LEARNING FOR PROTEIN-BASED DRUG DISCOVERY

Menten AI selects Xanadu's open-source library PennyLane to leverage quantum simulation and quantum machine learning capabilities to develop novel protein-based drugs.

August 16, 2021

Menten AI Leverages AWS, AI, and Quantum Computing to Create New and Improved Drugs

Menten AI created the world’s first protein designed on a quantum computer.

June 23, 2021

Biology begins to tangle with quantum computing.

Quantum computing promises plenty, such as how it can massively accelerate some bioinformatics calculations.

September 29, 2020

D-Wave unveils its most powerful quantum computer to date

D-Wave Systems, the company that was the first to sell a commercial quantum computer, has unveiled its newest and most powerful model to date.

August 10, 2020

How Business Can Use Quantum Computing Right Now (Not 10 Years Into The Future)

CEO of PCIS. Entrepreneur with a deep focus on technology. Helping companies strategize, innovate and grow.

June 29, 2020

Menten AI’s combination of buzzword bingo brings AI and quantum computing to drug discovery

Menten AI has an impressive founding team and a pitch that combines some of the hottest trends in tech to pursue one of the biggest problems in healthcare — new drug discovery.